• Iconix Brand Group, Inc in connection with the acquisition of remaining interests in (i) Iconix Europe LLC, (ii) Iconix MENA Ltd and (iii) Iconix SE Asia Limited from GBG International Holding Company Limited (in administration).
    • Zyla Life Sciences in its merger with Assertio Therapeutics, Inc.
    • Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain, in its debt restructuring and pending acquisition of four FDA-approved, non-narcotic pain products from Iroko Pharmaceuticals, Inc.
    • EnTrust Global on its acquisition from Franklin Templeton of the 65% interest that Legg Mason, Inc. holds in EnTrust Global.
    • StoneCastle Asset Management and its parent StoneCastle Partners LLC on its sale of StoneCastle Asset Management’s Bank Investment Platform to ArrowMark Partners.
    • Further Global Capital Management on its acquisition of U.S.-headquartered Payment Alliance International (PAI), the nation’s largest privately- held ATM provider.
    • Biogen, Inc., in its spin-off of Bioverativ Inc., with an initial market capitalization of approximately US$4.8 billion.
    • Citrix Systems, Inc., in its spin-off and sale of its “GoTo” software business to LogMeIn, Inc., valued at approximately US$1.8 billion.
    • IntraLinks Holdings, Inc., in its auction and sale process resulting in a sale to Synchronoss Technologies, Inc., valued at approximately US$821 million.
    • Novell, Inc., in responding to an unsolicited acquisition offer in a process that resulted in an auction and sale of the company in a concurrent patent sale and merger valued at US$2.2 billion. 
    • Gilead Sciences, Inc., in its acquisition of clinical program asset from a German private biopharmaceutical company in a transaction worth up to US$470 million.
    • Broadcom Corporation in its US$165 million acquisition of a modem-related division of Japanese semiconductor manufacturer Renesas Electronics.
    • Vocus, Inc., in its auction and sale process resulting in a sale to GTCR valued at US$450 million.
    • Rhythmia Medical, Inc., in its US$265 million sale to Boston Scientific Corporation.
    • Broadcom Corporation in its US$3.7 billion acquisition of NetLogic Microsystems Inc.
    • The RMR Group, Inc., in its public offering by way of a distribution through its public shareholders.

    Includes matters handled at Dechert or prior to joining the firm.